Literature DB >> 28880020

Novel GP64 envelope variants for improved delivery to human airway epithelial cells.

P L Sinn1,2, B-Y Hwang3, N Li1,2, J L S Ortiz3, E Shirazi1, K R Parekh4, A L Cooney2,5, D V Schaffer3, P B McCray1,2,5.   

Abstract

Lentiviral vectors pseudotyped with the baculovirus envelope protein GP64 transduce primary cultures of human airway epithelia (HAE) at their apical surface. Our goal in this study was to harness a directed evolution approach to develop a novel envelope glycoprotein with increased transduction properties for HAE. Using error-prone PCR, a library of GP64 mutants was generated and used to prepare a diverse pool of lentiviral virions pseudotyped with GP64 variants. The library was serially passaged on HAE and three GP64 mutations were recovered. Single-, double- and the triple-combination mutant envelope glycoproteins were compared with wild-type GP64 for their ability to transduce HAE. Our results suggest that lentiviral vectors pseudotyped with evolved GP64 transduced HAE with greater efficiency than wild-type GP64. This effect was not observed in primary cultures of porcine airway epithelial cells, suggesting that the directed evolution protocol was species specific. In summary, our studies indicate that serial passage of a GP64 mutant library yielded specific variants with improved HAE cell tropism, yielding tools with the potential to improve the success of gene therapy for airway diseases.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28880020      PMCID: PMC5759328          DOI: 10.1038/gt.2017.78

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  38 in total

Review 1.  Surface-Engineered Viral Vectors for Selective and Cell Type-Specific Gene Delivery.

Authors:  Christian J Buchholz; Thorsten Friedel; Hildegard Büning
Journal:  Trends Biotechnol       Date:  2015-10-20       Impact factor: 19.536

2.  Random mutagenesis by PCR.

Authors:  D S Wilson; A D Keefe
Journal:  Curr Protoc Mol Biol       Date:  2001-05

3.  An evolved adeno-associated viral variant enhances gene delivery and gene targeting in neural stem cells.

Authors:  Jae-Hyung Jang; James T Koerber; Jung-Suk Kim; Prashanth Asuri; Tandis Vazin; Melissa Bartel; Albert Keung; Inchan Kwon; Kook In Park; David V Schaffer
Journal:  Mol Ther       Date:  2011-01-11       Impact factor: 11.454

4.  Feline immunodeficiency virus vectors persistently transduce nondividing airway epithelia and correct the cystic fibrosis defect.

Authors:  G Wang; V Slepushkin; J Zabner; S Keshavjee; J C Johnston; S L Sauter; D J Jolly; T W Dubensky; B L Davidson; P B McCray
Journal:  J Clin Invest       Date:  1999-12       Impact factor: 14.808

Review 5.  Ferret and pig models of cystic fibrosis: prospects and promise for gene therapy.

Authors:  Ziying Yan; Zoe A Stewart; Patrick L Sinn; John C Olsen; Jim Hu; Paul B McCray; John F Engelhardt
Journal:  Hum Gene Ther Clin Dev       Date:  2015-02-12       Impact factor: 5.032

Review 6.  Adeno-associated virus vectors and neurological gene therapy.

Authors:  David S Ojala; Dominic P Amara; David V Schaffer
Journal:  Neuroscientist       Date:  2014-02-20       Impact factor: 7.519

7.  Chimeric antigen receptor-modified T cells for acute lymphoid leukemia.

Authors:  Stephan A Grupp; Michael Kalos; David Barrett; Richard Aplenc; David L Porter; Susan R Rheingold; David T Teachey; Anne Chew; Bernd Hauck; J Fraser Wright; Michael C Milone; Bruce L Levine; Carl H June
Journal:  N Engl J Med       Date:  2013-03-25       Impact factor: 91.245

8.  Productive infection of human peripheral blood mononuclear cells by feline immunodeficiency virus: implications for vector development.

Authors:  J Johnston; C Power
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

9.  DNA shuffling of adeno-associated virus yields functionally diverse viral progeny.

Authors:  James T Koerber; Jae-Hyung Jang; David V Schaffer
Journal:  Mol Ther       Date:  2008-08-26       Impact factor: 11.454

10.  Lentiviral vector gene transfer to porcine airways.

Authors:  Patrick L Sinn; Ashley L Cooney; Mayumi Oakland; Douglas E Dylla; Tanner J Wallen; Alejandro A Pezzulo; Eugene H Chang; Paul B McCray
Journal:  Mol Ther Nucleic Acids       Date:  2012-11-27       Impact factor: 10.183

View more
  13 in total

1.  Viral Vectors, Animal Models, and Cellular Targets for Gene Therapy of Cystic Fibrosis Lung Disease.

Authors:  Yinghua Tang; Ziying Yan; John F Engelhardt
Journal:  Hum Gene Ther       Date:  2020-04-15       Impact factor: 5.695

2.  Improving Baculovirus Transduction of Mammalian Cells by Incorporation of Thogotovirus Glycoproteins.

Authors:  Liangbo Hu; Yimeng Li; Fei Deng; Zhihong Hu; Hualin Wang; Manli Wang
Journal:  Virol Sin       Date:  2019-06-14       Impact factor: 4.327

3.  Highly Efficient Gene Editing of Cystic Fibrosis Patient-Derived Airway Basal Cells Results in Functional CFTR Correction.

Authors:  Shingo Suzuki; Ana M Crane; Varada Anirudhan; Cristina Barillà; Nadine Matthias; Scott H Randell; Andras Rab; Eric J Sorscher; Jenny L Kerschner; Shiyi Yin; Ann Harris; Matthew Mendel; Kenneth Kim; Lei Zhang; Anthony Conway; Brian R Davis
Journal:  Mol Ther       Date:  2020-04-29       Impact factor: 11.454

Review 4.  Gene Therapy for Acute Respiratory Distress Syndrome.

Authors:  Jing Liu; David A Dean
Journal:  Front Physiol       Date:  2022-01-17       Impact factor: 4.566

Review 5.  Advances in gene therapy for cystic fibrosis lung disease.

Authors:  Ziying Yan; Paul B McCray; John F Engelhardt
Journal:  Hum Mol Genet       Date:  2019-10-01       Impact factor: 5.121

Review 6.  New Directions in Pulmonary Gene Therapy.

Authors:  Amber Vu; Paul B McCray
Journal:  Hum Gene Ther       Date:  2020-09       Impact factor: 4.793

Review 7.  Baculovirus as a Tool for Gene Delivery and Gene Therapy.

Authors:  Chikako Ono; Toru Okamoto; Takayuki Abe; Yoshiharu Matsuura
Journal:  Viruses       Date:  2018-09-19       Impact factor: 5.048

Review 8.  Lessons learned from lung and liver in-vivo gene therapy: implications for the future.

Authors:  Joost van Haasteren; Stephen C Hyde; Deborah R Gill
Journal:  Expert Opin Biol Ther       Date:  2018-08-10       Impact factor: 4.388

Review 9.  Lentiviral Vectors for the Treatment and Prevention of Cystic Fibrosis Lung Disease.

Authors:  Laura I Marquez Loza; Eric C Yuen; Paul B McCray
Journal:  Genes (Basel)       Date:  2019-03-14       Impact factor: 4.096

10.  Establishment of Primary Transgenic Human Airway Epithelial Cell Cultures to Study Respiratory Virus-Host Interactions.

Authors:  Hulda R Jonsdottir; Sabrina Marti; Dirk Geerts; Regulo Rodriguez; Volker Thiel; Ronald Dijkman
Journal:  Viruses       Date:  2019-08-13       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.